Drug intelligence / Profile preview

lactated Ringer's solution (Baxter International Inc.)

Development stage
Unknown
Lead developer
Enrique de Madaria
Modality
Small Molecules
Administration
Intravenous, Subcutaneous, Topical
01

Overview

Lactated Ringer's solution (LR) is a sterile, isotonic, physiologically balanced crystalloid intravenous fluid used primarily for fluid resuscitation, volume substitution, and electrolyte replenishment. It is composed of sodium chloride, sodium lactate, potassium chloride, and calcium chloride in water. Unlike normal saline, lactated Ringer's solution contains sodium lactate, which is metabolized by the liver into bicarbonate, acting as a buffering agent to mitigate metabolic acidosis. In the context of acute pancreatitis (AP), lactated Ringer's solution has been investigated in multiple clinical trials (such as the WATERFALL and WATERLAND trials) led by investigators like Enrique de Madaria. Evidence suggests that LR may exert anti-inflammatory effects in AP compared to normal saline, potentially reducing systemic inflammatory response syndrome (SIRS), C-reactive protein (CRP) levels, and overall disease severity. The solution is manufactured as a generic product by multiple pharmaceutical companies, including Baxter, B. Braun, and Fresenius Kabi.

Other names
lactated Ringer solutionRinger's lactate solutionRinger's lactatesodium lactate solutionHartmann's solutioncompound sodium lactateRinger-lactateLRSLR

Beyond the preview

Go deeper on lactated Ringer's solution (Baxter International Inc.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lactated Ringer's solution (Baxter International Inc.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call